Inovio Pharmaceuticals Inc (NASDAQ:INO)

12.00
Delayed Data
As of 3:59pm ET
 +0.32 / +2.74%
Today’s Change
3.60
Today|||52-Week Range
33.79
+35.59%
Year-to-Date
Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy?
Feb 22 / Zacks.com - Paid Partner Content
Better Coronavirus Stock: Inovio Pharmaceuticals vs. Vaxart
Feb 15 / MotleyFool.com - Paid Partner Content
Inovio (INO) to Report Q4 Earnings: What's in the Cards?
Feb 22 / Zacks.com - Paid Partner Content
Why Inovio Pharmaceuticals Stock Is Soaring Today
Feb 12 / MotleyFool.com - Paid Partner Content
Are Short-Sellers Right About Inovio?
Feb 21 / MotleyFool.com - Paid Partner Content
Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?
Feb 12 / MotleyFool.com - Paid Partner Content
Inovio Pharmaceuticals (INO) Dips More Than Broader Markets: What You Should Know
Feb 19 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close11.68
Today’s open11.80
Day’s range11.50 - 12.17
Volume373,037
Average volume (3 months)13,776,193
Market cap$2.8B
Data as of 3:59pm ET, 02/24/2021

Growth & Valuation

Earnings growth (last year)-15.39%
Earnings growth (this year)+4.50%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-86.51%
P/E ratioNM
Price/Sales79.23
Price/Book408.68

Competitors

----
----
LGNDLigand Pharmaceutica...+4.80+3.40%
ENDPEndo International P...+0.06+0.66%
Data as of 3:59pm ET, 02/24/2021

Financials

Next reporting dateMarch 2, 2021
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$4.1M
Annual profit (last year)-$119.4M
Net profit margin-2,902.75%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts